Search by Drug Name or NDC

    NDC 00527-4961-32 Levothyroxine Sodium 175 ug/1 Details

    Levothyroxine Sodium 175 ug/1

    Levothyroxine Sodium is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is LEVOTHYROXINE SODIUM.

    Product Information

    NDC 00527-4961
    Product ID 0527-4961_0b273fe1-0b63-ec03-e063-6294a90a5ab6
    Associated GPIs 28100010100155
    GCN Sequence Number 079369
    GCN Sequence Number Description levothyroxine sodium CAPSULE 175 MCG ORAL
    HIC3 P3A
    HIC3 Description THYROID HORMONES
    GCN 45862
    HICL Sequence Number 002849
    HICL Sequence Number Description LEVOTHYROXINE SODIUM
    Brand/Generic Generic
    Proprietary Name Levothyroxine Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name levothyroxine sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 175
    Active Ingredient Units ug/1
    Substance Name LEVOTHYROXINE SODIUM
    Labeler Name Lannett Company, Inc.
    Pharmaceutical Class Thyroxine [CS], l-Thyroxine [EPC]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA021924
    Listing Certified Through 2024-12-31

    Package

    NDC 00527-4961-32 (00527496132)

    NDC Package Code 0527-4961-32
    Billing NDC 00527496132
    Package 3 BLISTER PACK in 1 CARTON (0527-4961-32) / 10 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 2020-11-02
    NDC Exclude Flag N
    Pricing Information N/A